Christine Pausch

Dresden, SN, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Association Between Invasive Cardiac Hemodynamics and Kidney Function in Patients with Pulmonary Hypertension.

Association Between Invasive Cardiac Hemodynamics and Kidney Function in Patients with Pulmonary Hypertension.

Journal: Kidney360

Published: January 07, 2026

Sex-Specific Phenotypes and Outcomes in Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Disease: Results from the INSIGHTS-ILD Registry.

Sex-Specific Phenotypes and Outcomes in Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Disease: Results from the INSIGHTS-ILD Registry.

Journal: Respiration; international review of thoracic diseases

Published: December 31, 2025

Rationale, Design and Methods of the Filgotinib Initial Response Study in Rheumatoid Arthritis (FIRST-RA).

Rationale, Design and Methods of the Filgotinib Initial Response Study in Rheumatoid Arthritis (FIRST-RA).

Journal: Rheumatology and therapy

Published: October 09, 2025

Add-on therapy with parenteral prostacyclin analogues in patients with pulmonary arterial hypertension: Insights from the COMPERA registry.

Add-on therapy with parenteral prostacyclin analogues in patients with pulmonary arterial hypertension: Insights from the COMPERA registry.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: August 31, 2025

Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in Pulmonary Hypertension in Interstitial Lung Disease: A PVRI GoDeep Meta-Registry Analysis.

Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in Pulmonary Hypertension in Interstitial Lung Disease: A PVRI GoDeep Meta-Registry Analysis.

Journal: American journal of respiratory and critical care medicine

Published: August 07, 2025

First 100 patients receiving long-acting growth hormone therapy: real-world evaluation from INSIGHTS-GHT registry.

First 100 patients receiving long-acting growth hormone therapy: real-world evaluation from INSIGHTS-GHT registry.

Journal: Orphanet journal of rare diseases

Published: March 24, 2025

Long-Term Mortality and Morbidity Impact on Patients with Pulmonary Arterial Hypertension (PAH) If Access to Sotatercept Is Delayed: A Simulation Model.

Long-Term Mortality and Morbidity Impact on Patients with Pulmonary Arterial Hypertension (PAH) If Access to Sotatercept Is Delayed: A Simulation Model.

Journal: Advances in therapy

Published: March 14, 2025

Survival in patients with chronic thromboembolic pulmonary hypertension treated with riociguat versus other medications: a COMPERA analysis.

Survival in patients with chronic thromboembolic pulmonary hypertension treated with riociguat versus other medications: a COMPERA analysis.

Journal: ERJ open research

Published: February 15, 2025

Mono and combination therapies in pulmonary arterial hypertension patients with comorbidities: A COMPERA analysis.

Mono and combination therapies in pulmonary arterial hypertension patients with comorbidities: A COMPERA analysis.

Journal: ESC heart failure

Published: January 20, 2025

Real-life characteristics and management of patients with fibrosing interstitial lung disease: INSIGHTS-ILD registry.

Real-life characteristics and management of patients with fibrosing interstitial lung disease: INSIGHTS-ILD registry.

Journal: ERJ open research

Published: September 18, 2024

Population Health Model Predicting the Long-Term Impact of Sotatercept on Morbidity and Mortality in Patients with Pulmonary Arterial Hypertension (PAH).

Population Health Model Predicting the Long-Term Impact of Sotatercept on Morbidity and Mortality in Patients with Pulmonary Arterial Hypertension (PAH).

Journal: Advances in therapy

Published: August 15, 2023

Performance of the ESC/ERS 4-strata risk stratification model for pulmonary arterial hypertension with missing variables.

Performance of the ESC/ERS 4-strata risk stratification model for pulmonary arterial hypertension with missing variables.

Journal: The European respiratory journal

Published: June 16, 2023

Showing 1-12 of 36

Last Updated: 09/26/2026